Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Amitesh C. Roy, Jeremy Shapiro, Matt Burge, Christos S. Karapetis, Nick Pavlakis, Eva Segelov, Ian Chau, Florian Lordick, Li Tong Chen, Andrew Barbour, Niall Tebbutt, Tim Price

    Research output: Contribution to journalReview article

    Abstract

    Introduction: A multimodal approach in operable early-stage oesophago-gastric (OG) cancer has evolved in the last decade, leading to improvement in overall outcomes. Areas covered: A review of the published literature and conference abstracts was undertaken on the topic of optimal adjunctive chemotherapy or chemoradiotherapy in early-stage OG cancers. This review article focuses on the current evidence pertaining to neoadjuvant and perioperative strategies in curable OG cancers including the evolving landscape of immunotherapy and targeted drugs in this setting. Expert commentary: Adjunctive therapies in the form of preoperative chemo-radiotherapy (CRT) or chemotherapy and perioperative chemotherapy over surgery alone improve outcomes in patients with operable OG cancer. Although there are variations in practice around the world, a multi-disciplinary approach to patient care is of paramount importance. Immunotherapy and on treatment functional imaging are two examples of emerging strategies to improve the outcome for early-stage patients. A better understanding of the molecular biology of this disease may help overcome the problem of tumor heterogeneity and enable more rationally designed and targeted therapeutic interventions in the future.

    Original languageEnglish
    Pages (from-to)305-324
    Number of pages20
    JournalExpert Review of Anticancer Therapy
    Volume20
    Issue number4
    DOIs
    Publication statusPublished - 12 Apr 2020

    Keywords

    • adjuvant
    • chemotherapy
    • Gastric
    • oesophageal
    • peri operative

    Fingerprint Dive into the research topics of 'Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty'. Together they form a unique fingerprint.

  • Cite this

    Roy, A. C., Shapiro, J., Burge, M., Karapetis, C. S., Pavlakis, N., Segelov, E., Chau, I., Lordick, F., Chen, L. T., Barbour, A., Tebbutt, N., & Price, T. (2020). Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Expert Review of Anticancer Therapy, 20(4), 305-324. https://doi.org/10.1080/14737140.2020.1746185